MedPath

A Randomized Controlled Trial of a Nurse Delivered Stage-matched Smoking Cessation Intervention to Promote Heart Health of Cardiac Patients

Not Applicable
Completed
Conditions
Smoking Cessation
Smoking
Registration Number
NCT00563199
Lead Sponsor
Hospital Authority, Hong Kong
Brief Summary

This study is a randomized controlled trial designed to evaluate the effectiveness of a nurse delivered stage-matched intervention to cardiac patients for cessation of tobacco use. Review of literature shows that there is a clear lack of empirical evidence on (1) using nurses to deliver stage-matched smoking cessation interventions, and (2) the effectiveness of such intervention for cardiac patients in Chinese populations. The ultimate goal of the intervention achieve a higher quit rate in the intervention group than in the controls. In addition, the change in the patient's smoking behaviour such as reduction of the number of cigarettes smoked, and progression to a higher stage of readiness to quit, will also be measured. This study is the first step to address the urgently needed data for (1) promoting the delivery of nurse-run stage-matched smoking cessation interventions to help patients stop smoking, (2) developing smoking cessation policy and programmes in the hospitals and for the health care system, and (3) contributing an evidence-based approach to orientate clinical services towards prevention, so as to reduce premature deaths and the enormous disease burden of our society.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1824
Inclusion Criteria
  • Patient who is admitted to the participating centres and is a current smoker who has smoked daily in the past 7 days prior to hospitalization.
  • Patient speaks and reads Cantonese/Chinese
Exclusion Criteria
  • Patient who is clinically too ill and not suitable to complete questionnaire and/or receive intervention.
  • Patient who does not speak or read Chinese

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Quitting--to achieve higher quit rate in the cardiac patients (coronary artery disease) who are smokerscontinuous abstinence for one month at the time of 3, 6 and 12 month follow up
Secondary Outcome Measures
NameTimeMethod
Reduction of the number of cigarettes smokedat the time of 3, 6 and 12 month follow up
Progression to a higher stage of readiness to quitat the time of 3, 6 and 12 month follow up

Trial Locations

Locations (10)

Caritas Medical Centre

🇨🇳

Hong Kong, China

Pamela Youde Nethersole Eastern Hospital

🇨🇳

Hong Kong, China

Princess Margaret Hospital

🇨🇳

Hong Kong, China

Ruttonjee Hospital / Tang Shiu Kin Hospital

🇨🇳

Hong Kong, China

Queen Elizabeth Hospital

🇨🇳

Hong Kong, China

Queen Mary Hospital

🇨🇳

Hong Kong, China

Tuen Mun Hospital

🇨🇳

Hong Kong, China

Tseung Kwan O Hospital

🇨🇳

Hong Kong, China

Tung Wah Hospital

🇨🇳

Hong Kong, China

United Christian Hospital

🇨🇳

Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath